FDA

After decades of limited progress in treating sickle cell disease, we have reached an historical moment with two new gene therapies.

The FDA approved an oral drug, based on foundational research conducted at CHOP, to treat a rare, severe bone disease. More In The News.

Learn about a first-of-its-kind FDA approval and a PCORI project that aims to turn evidence-based research into clinical practice more quickly.

Our most engaging stories of 2020 highlight moments of positivity, hope, and inspiration in a year of challenge and change.

David Teachey, MD, and colleagues are exploring convalescent plasma as a treatment for COVID-19, the disease caused by SARS-CoV-2.

Read about a breakthrough peanut allergy treatment, support for teen resilience, healthcare disparities in pain treatment, and pediatric medical device awards.

The FDA approved the first-ever oral immunotherapy to treat peanut allergies.

September marks National Childhood Cancer Awareness Month, and this year at Children's Hospital of Philadelphia, we kick-started the commemorative period on the heels of exciting news about breakthroughs in pediatric cancer immunotherapy research.

For medical devices, as with many medicines, the market for children is a small fraction of the adult market, and there are far fewer child-sized devices. But the need for pediatric medical devices exists, even if proper devices may not.